<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intraarterial thrombolytic therapy can be life-saving in patients with vertebrobasilar occlusion </plain></SENT>
<SENT sid="1" pm="."><plain>Thrombotic occlusions of the internal carotid artery or middle cerebral artery often result in disabling <z:e sem="disease" ids="C1262005" disease_type="Disease or Syndrome" abbrv="">ischemic cerebral infarctions</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Local fibrinolysis may help to minimize the neurological sequelae </plain></SENT>
<SENT sid="3" pm="."><plain>Indications and contraindications for such a therapy are not yet well established, and more discussion is needed </plain></SENT>
<SENT sid="4" pm="."><plain>During the last 2 years we have treated 18 patients with occlusions of vessels supplying the brain by means of local intraarterial thrombolytic therapy with urokinase </plain></SENT>
<SENT sid="5" pm="."><plain>These included 5 patients who presented with internal carotid/middle cerebral <z:mp ids='MP_0006134'>artery occlusions</z:mp>, 3 of whom left the hospital with only minor neurological deficits while 2 died despite therapy </plain></SENT>
<SENT sid="6" pm="."><plain>The other 13 patients had <z:hpo ids='HP_0011009'>acute</z:hpo> vertebrobasilar occlusion: 6 patients survived, 3 with a good general condition and 2 with <z:e sem="disease" ids="C0023944" disease_type="Disease or Syndrome" abbrv="">locked-in syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Technique, dosage of urokinase and patient selection are discussed as well as the outcome </plain></SENT>
</text></document>